NASDAQ: DFNST3 Defense Inc Stock
$2.13-0.08 (-3.62%)
Updated Feb 11, 2026
DFNS Price
$2.13
Fair Value Price
N/A
Market Cap
$35.46M
52 Week Low
$1.90
52 Week High
$26.21
P/E
-0.07x
P/B
-1.17x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$71.18M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.44
Operating Cash Flow
-$6M
Beta
-0.44
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DFNS Overview
Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. The company primarily offers software, technology, customer sales and marketing, and risk management technology hardware and software solutions. It also offers financial services to enable conversion of fiat currencies to cryptocurrencies and vice versa. The company was formerly known as Compliance & Risk Management Solutions Inc. and changed its name to Nukkleus Inc. The company was incorporated in 2013 and is headquartered in Jersey City, New Jersey. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DFNS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
DFNS
Ranked#139 of 172
Ranked#139 of 172
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $2.69 | A | |
| $72.36 | A | |
| $11.16 | A |
Be the first to know about important DFNS news, forecast changes, insider trades & much more!
DFNS News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DFNS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DFNS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DFNS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
DFNS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more DFNS due diligence checks available for Premium users.
Valuation
DFNS fair value
Fair Value of DFNS stock based on Discounted Cash Flow (DCF)
Price
$2.13
Fair Value
-$5.64
Undervalued by
137.74%
DFNS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DFNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.07x
Industry
38.58x
Market
44.56x
DFNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.17x
Industry
0x
DFNS's financial health
Profit margin
Revenue
$0.0
Net Income
-$16.4M
Profit Margin
0%
DFNS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$13.3M
Liabilities
$43.7M
Debt to equity
-1.44
DFNS's short-term liabilities ($43.63M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DFNS's short-term assets ($13.12M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DFNS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DFNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.5M
Investing
-$2.0M
Financing
$9.2M
DFNS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DFNS vs App Stocks
T3 Defense Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.